GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,000 | -4.2% | 539 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $24,000 | -99.9% | 539 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $20,595,000 | -4.0% | 539 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $21,463,000 | +11.6% | 539 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $19,237,000 | +96085.0% | 539 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $20,000 | -99.9% | 539 | 0.0% | 0.00% | -66.7% |
| Q3 2020 | $20,288,000 | -7.8% | 539 | -19.4% | 0.00% | 0.0% |
| Q2 2020 | $22,007,000 | +7.8% | 669 | +24.1% | 0.00% | -25.0% |
| Q1 2020 | $20,423,000 | -74.6% | 539 | -68.5% | 0.00% | -63.6% |
| Q4 2019 | $80,494,000 | +110165.8% | 1,713 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $73,000 | -99.9% | 1,713 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $68,554,000 | -4.2% | 1,713 | 0.0% | 0.01% | -8.3% |
| Q1 2019 | $71,586,000 | +357830.0% | 1,713 | +217.8% | 0.01% | +200.0% |
| Q4 2018 | $20,000 | -55.6% | 539 | -52.7% | 0.00% | -55.6% |
| Q3 2018 | $45,000 | – | 1,139 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |